HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Schwaller Selected Research

Parvalbumins

3/2015Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities.
4/2009Microcalcification after excitotoxicity is enhanced in transgenic mice expressing parvalbumin in all neurones, may commence in neuronal mitochondria and undergoes structural modifications over time.
8/2008The role of parvalbumin and calbindin D28k in experimental scrapie.
4/2004Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures.
6/2003Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant.
8/2002Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells.
7/2001Deficiency in parvalbumin increases fatigue resistance in fast-twitch muscle and upregulates mitochondria.
9/2000Tetanus relaxation of fast skeletal muscles of the mouse made parvalbumin deficient by gene inactivation.
1/2000Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Schwaller Research Topics

Disease

3Colonic Neoplasms (Colon Cancer)
01/2002 - 08/2000
2Seizures (Absence Seizure)
04/2004 - 01/2000
2Carcinoma (Carcinomatosis)
08/2001 - 08/2001
1Autistic Disorder (Autism)
03/2015
1Calcinosis
04/2009
1Scrapie
08/2008
1Prion Diseases (Transmissible Spongiform Encephalopathies)
08/2008
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2004
1Hypertrophy
06/2003
1Neuroblastoma
08/2002
1Shock
08/2001
1Neoplasms (Cancer)
08/2001
1Fatigue
07/2001
1Tetanus
09/2000
1Temporal Lobe Epilepsy
01/2000

Drug/Important Bio-Agent (IBA)

9ParvalbuminsIBA
03/2015 - 01/2000
4Calbindin 2IBA
08/2002 - 01/2000
3Calcium-Binding ProteinsIBA
08/2008 - 01/2000
2Glutamic Acid (Glutamate)FDA Link
01/2004 - 08/2002
2CalbindinsIBA
08/2002 - 01/2000
1Calbindin 1IBA
08/2008
1Biomarkers (Surrogate Marker)IBA
08/2008
1LectinsIBA
08/2008
1Pentylenetetrazole (Metrazol)IBA
04/2004
1CalciumIBA
01/2004
1Proteins (Proteins, Gene)FDA Link
08/2002
1EpitopesIBA
01/2002
1Monoclonal AntibodiesIBA
01/2002
1AntigensIBA
01/2002
1Glutamate Receptors (Glutamate Receptor)IBA
08/2001
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2001
1Protein Isoforms (Isoforms)IBA
08/2001
1Butyric Acid (Butanoic Acid)IBA
08/2001
1Neuropeptide YIBA
01/2000
1Kainic Acid (Kainate)IBA
01/2000